Clinical Trial of Pulmonary Cryptococcosis in China
NCT02503449 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 260
Last updated 2015-07-21
Summary
The purpose of the study:1.Improve the understanding of the risk factors of pulmonary cryptococcosis;2.Improve the awareness of pulmonary cryptococcosis clinical and imaging manifestations;3.Grasp pulmonary cryptococcosis patients of clinical and imaging manifestations in different conditions;4.Learn about antibacterial activity of antifungal drugs for cryptococcosis in China.
Conditions
- Cryptococcosis
Sponsors & Collaborators
-
Chinese PLA General Hospital
collaborator OTHER -
Beijing Chao Yang Hospital
collaborator OTHER -
Ministry of Health, China
collaborator OTHER_GOV -
Peking University Third Hospital
collaborator OTHER -
Tianjin Medical University General Hospital
collaborator OTHER -
First Hospital of China Medical University
collaborator OTHER -
Shengjing Hospital
collaborator OTHER -
Second Hospital of Jilin University
collaborator OTHER -
Shandong Provincial Hospital
collaborator OTHER_GOV -
Huadong Hospital
collaborator OTHER -
Nanjing PLA General Hospital
collaborator OTHER -
Fuzhou General Hospital
collaborator OTHER -
Guangzhou Institute of Respiratory Disease
collaborator OTHER -
Wuhan TongJi Hospital
collaborator OTHER -
Xi'an Jiaotong University
collaborator OTHER -
Guizhou Provincial People's Hospital
collaborator OTHER -
Shenyang Military General Hospital
collaborator UNKNOWN -
The Second Hospital of Hebei Medical University
collaborator OTHER -
Xiangya Hospital of Central South University
collaborator OTHER -
Fujian Provincial Hospital
collaborator OTHER -
Fuzhou Pulmonary Hospital of Fujian
collaborator OTHER -
Southwest Hospital, China
collaborator OTHER -
First Affiliated Hospital of Zhejiang University
collaborator OTHER -
Wenzhou Medical University
collaborator OTHER -
Shanghai Zhongshan Hospital
collaborator OTHER -
The First Affiliated Hospital of Nanchang University
collaborator OTHER -
Longyan City First Hospital
collaborator OTHER -
Zhixin Liang
lead OTHER
Principal Investigators
-
Zhixin Liang, Doctor · Chinese PLA General Hospital
-
Zhen Wang · Beijing Chao Yang Hospital
-
Yanming Li · Ministry of Health, China
-
Lina Sun · Peking University Third Hospital
-
Jie Cao · Tianjin Medical University General Hospital
-
Yunzhuo Chu · First Hospital of China Medical University
-
Zhijie Zhang · Shengjing Hospital
-
Yufen Jin · Second Hospital of Jilin University
-
Xiaobin Ma · Shandong Provincial Hospital
-
Yanping Zhu · Huadong Hospital
-
Xin Su · Nanjing PLA General Hospital
-
Guoxiang Lai · Fuzhou General Hospital
-
Feng Ye · Guangzhou Institute of Respiratory Disease
-
Shengdao Xiong · Wuhan TongJi Hospital
-
Lan Yang · Xi'an Jiaotong University
-
Hong Yu · Guizhou Provincial People's Hospital
-
wencheng Xue · Shenyang Military General Hospital
-
Yadong Yuan · The Second Hospital of Hebei Medical University
-
Chengping Hu · Xiangya Hospital of Central South University
-
Baosong Xie · Fujian Provincial Hospital
-
Xiaohong Chen · Fuzhou Pulmonary Hospital of Fujian
-
Xiangdong Zhou · Southwest Hospital, China
-
Wenjiang Ma · First Affiliated Hospital of Zhejiang University
-
Yuping Li · Wenzhou Medical University
-
Hongni Jiang · Shanghai Zhongshan Hospital
-
Wei Bai · The First Affiliated Hospital of Nanchang University
-
Sucheng Zhong · Longyan City First Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-12-31
- Primary Completion
- 2016-12-31
- Completion
- 2017-12-31
More Related Trials
-
ManagemEnt of Antifungal Drug in Invasive Aspergillosis:a Real-word Study
NCT06028451 ·Status: RECRUITING
-
Comprehensive Diagnosis and Treatment Strategy for Opportunistic Fungal Infections in AIDS Patients
NCT05153005 ·Status: UNKNOWN
-
A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal Infections
NCT00288197 ·Status: COMPLETED ·Phase: PHASE4
-
Isavuconazole in Critically Ill Patients: Efficacy and Safety
NCT07080359 ·Status: NOT_YET_RECRUITING
-
A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia
NCT01982071 ·Status: TERMINATED ·Phase: PHASE4
-
Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis
NCT02646774 ·Status: TERMINATED ·Phase: PHASE4
-
Assessing Diagnostic Methods for Invasive Fungal Disease in Lung Transplant Recipients
NCT06654076 ·Status: COMPLETED
-
Systemic Fungal Infections in ICU Patients
NCT03292224 ·Status: UNKNOWN
-
Fungal Infection Susceptibility
NCT00001352 ·Status: RECRUITING
-
Pharmacokinetics and Pharmacodynamics of Caspofungin (Cancidas ®) and Drug Tolerance of Fungi to Patients With an Invasive Fungal Infection in the Intensive Care Unit
NCT02510053 ·Status: UNKNOWN ·Phase: NA
-
CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult Patients
NCT02100761 ·Status: UNKNOWN
-
Efficacy Of Itraconazole In Chronic Cavitary Pulmonary Aspergillosis
NCT01259336 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase I Study to Assess the Effect of Itraconazole and Rifampicin on Pharmacokinetics Profile of BPI-7711
NCT04135833 ·Status: COMPLETED ·Phase: PHASE1
-
Itraconazole Therapy In Bronchiectasis With Airway Mold
NCT07283497 ·Status: RECRUITING ·Phase: PHASE4
-
Retrospective Analysis of the Epidemiological Change and Determinants of Prognosis of Talaromycosisof Human Immunodeficiency Virus Negative Host in Guangxi
NCT03819348 ·Status: UNKNOWN
-
Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors
NCT04738955 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Study of ABCD in the Treatment of Cryptococcal Meningitis
NCT05471063 ·Status: UNKNOWN ·Phase: NA
-
Posaconazole for Pulmonary Fungal Infection Prophylaxis in Hematopoietic Stem Cell Transplantation Patients
NCT04725942 ·Status: COMPLETED
-
Evaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCT
NCT00460330 ·Status: UNKNOWN
-
Azole Susceptibility and Resistance Mechanisms Surveys in Pathogenic Fungi by the CARST-fungi (2023-2024)
NCT06969703 ·Status: NOT_YET_RECRUITING
-
Amphotericin B for Non-HIV Cryptococcal Meningitis Patients
NCT06178627 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections
NCT02678598 ·Status: COMPLETED
-
Factors on Therapeutic Drug Monitoring and Safety of Voriconazole in Critically Ill Elderly Patients
NCT06137690 ·Status: RECRUITING
-
A Multicenter Observational Study of Invasive Candida Infections Among ICU Patients in China
NCT01253954 ·Status: UNKNOWN
-
A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B
NCT00002306 ·Status: COMPLETED ·Phase: NA